nickel has been researched along with lipid a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerletti, C; Molino, M; Romano, M | 1 |
| Jerala, R; Manček-Keber, M | 1 |
| Bhide, Y; de Haan, A; de Vries-Idema, J; Dong, W; Holtrop, M; Huckriede, A; Marsman, S; Meijerhof, T | 1 |
1 review(s) available for nickel and lipid a
| Article | Year |
|---|---|
Postulates for validating TLR4 agonists.
Topics: Cations, Divalent; Gene Expression Regulation; Humans; Immunologic Factors; Lipid A; Lymphocyte Antigen 96; Models, Molecular; Nickel; Paclitaxel; Protein Binding; Receptor Cross-Talk; Signal Transduction; Toll-Like Receptor 4 | 2015 |
2 other study(ies) available for nickel and lipid a
| Article | Year |
|---|---|
Endotoxic lipid A induces intracellular Ca2+ increase in human platelets.
Topics: Blood Platelets; Calcium; Egtazic Acid; Enzyme Activation; Fluorescent Dyes; Fura-2; Humans; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Lipid A; Manganese; Nickel; Protein Kinase C | 1991 |
Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine.
Topics: Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; Influenza Vaccines; Lipid A; Mice; Nickel; Nucleocapsid Proteins; RAW 264.7 Cells; RNA-Binding Proteins; T-Lymphocytes, Cytotoxic; Viral Core Proteins; Virosomes | 2018 |